Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-23-052043
Filing Date
2023-04-28
Accepted
2023-04-28 07:01:16
Documents
128
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F adag-20221231x20f.htm   iXBRL 20-F 3938927
2 EXHIBIT 2.5 adag-20221231xex2d5.htm EX-2.5 170877
3 EXHIBIT 8.1 adag-20221231xex8d1.htm EX-8.1 11821
4 EXHIBIT 12.1 adag-20221231xex12d1.htm EX-12.1 12597
5 EXHIBIT 12.2 adag-20221231xex12d2.htm EX-12.2 13770
6 EXHIBIT 13.1 adag-20221231xex13d1.htm EX-13.1 6110
7 EXHIBIT 13.2 adag-20221231xex13d2.htm EX-13.2 5728
8 EXHIBIT 15.1 adag-20221231xex15d1.htm EX-15.1 7544
9 EXHIBIT 15.2 adag-20221231xex15d2.htm EX-15.2 8943
10 EXHIBIT 15.3 adag-20221231xex15d3.htm EX-15.3 4506
11 EXHIBIT 15.4 adag-20221231xex15d4.htm EX-15.4 2026
12 EXHIBIT 15.5 adag-20221231xex15d5.htm EX-15.5 11283
18 GRAPHIC adag-20221231x20f002.jpg GRAPHIC 53507
19 GRAPHIC adag-20221231x20f003.jpg GRAPHIC 80299
20 GRAPHIC adag-20221231x20f004.jpg GRAPHIC 28887
21 GRAPHIC adag-20221231x20f005.jpg GRAPHIC 23799
22 GRAPHIC adag-20221231x20f006.jpg GRAPHIC 16255
23 GRAPHIC adag-20221231x20f007.jpg GRAPHIC 26970
24 GRAPHIC adag-20221231x20f008.jpg GRAPHIC 79087
25 GRAPHIC adag-20221231x20f009.jpg GRAPHIC 51524
26 GRAPHIC adag-20221231x20f010.jpg GRAPHIC 32417
27 GRAPHIC adag-20221231x20f011.jpg GRAPHIC 40602
28 GRAPHIC adag-20221231x20f012.jpg GRAPHIC 75950
29 GRAPHIC adag-20221231x20f013.jpg GRAPHIC 48657
30 GRAPHIC adag-20221231x20f014.jpg GRAPHIC 40401
31 GRAPHIC adag-20221231x20f015.jpg GRAPHIC 28893
32 GRAPHIC adag-20221231x20f016.jpg GRAPHIC 23222
33 GRAPHIC adag-20221231x20f017.jpg GRAPHIC 20711
34 GRAPHIC adag-20221231x20f018.jpg GRAPHIC 21959
35 GRAPHIC adag-20221231x20f019.jpg GRAPHIC 91148
36 GRAPHIC adag-20221231x20f020.jpg GRAPHIC 83248
37 GRAPHIC adag-20221231x20f021.jpg GRAPHIC 53219
38 GRAPHIC adag-20221231x20f022.jpg GRAPHIC 36629
39 GRAPHIC adag-20221231x20f023.jpg GRAPHIC 27166
40 GRAPHIC adag-20221231x20f024.jpg GRAPHIC 34294
41 GRAPHIC adag-20221231x20f025.jpg GRAPHIC 73552
42 GRAPHIC adag-20221231x20f026.jpg GRAPHIC 37793
43 GRAPHIC adag-20221231x20f029.jpg GRAPHIC 49728
44 GRAPHIC adag-20221231xex15d1001.jpg GRAPHIC 14746
45 GRAPHIC adag-20221231xex15d3001.jpg GRAPHIC 7056
  Complete submission text file 0001104659-23-052043.txt   15590659

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA adag-20221231.xsd EX-101.SCH 73297
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adag-20221231_cal.xml EX-101.CAL 82632
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adag-20221231_def.xml EX-101.DEF 203346
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE adag-20221231_lab.xml EX-101.LAB 660293
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adag-20221231_pre.xml EX-101.PRE 466080
122 EXTRACTED XBRL INSTANCE DOCUMENT adag-20221231x20f_htm.xml XML 1860066
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Filer) CIK: 0001818838 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39997 | Film No.: 23860078
SIC: 2834 Pharmaceutical Preparations